Posted by: fuadelhibri on: April 2, 2012
Originally posted on Gazette.net Fuad El-Hibri has started a financial consulting business. He’s started telecommunications businesses. But his most challenging venture has been the Rockville biotech he helped launch 14 years ago. Still, El-Hibri — CEO and board chairman of Emergent BioSolutions — says the challenges are worth it, because the rewards are so great from protecting [...]
Posted by: fuadelhibri on: February 3, 2012
ROCKVILLE, Md.–(BUSINESS WIRE)–Jan. 30, 2012– Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report financial results for the fourth quarter and full year 2011 on Thursday, March 8, 2012, after market close. Company management will host a conference call at 5:00 pm Eastern on March 8, 2012 to discuss the financial results for [...]
Posted by: fuadelhibri on: June 1, 2011
ROCKVILLE, Md., May 25, 2011 — Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Jefferies 2011 Global Healthcare Conference in New York on Tuesday, June 7, 2011 at 1:15 PM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate [...]
Posted by: fuadelhibri on: April 13, 2011
2010 revenues of $286.2 million 2010 net income of $51.7 million, or $1.63 per share, representing ninth consecutive year of profitability 2010 cash, investments and accounts receivable balance of $210.4 million 2011 forecast reaffirmed: total revenues of $320 to $340 million and net income of $35 to $45 million Emergent BioSolutions Inc. (NYSE: EBS) announced [...]
Posted by: fuadelhibri on: March 3, 2011
Comments expressed during tour of South African clinical trial site where Emergent’s TB vaccine candidate is expected to complete enrollment in April for its Phase IIb efficacy study ROCKVILLE, Md., Feb 25, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced that a joint delegation of Members of the European Parliament (MEPs) and representatives from [...]
Posted by: fuadelhibri on: January 7, 2011
By Marjorie Censer Monday, January 3, 2011 Fuad El-Hibri has lived in all sorts of exotic locales, working for Citicorp in Saudi Arabia, consulting for Booz Allen Hamilton in Indonesia and establishing mobile telecommunications businesses in Russia, Venezuela and El Salvador. But getting started in his current position as chief executive of Rockville-based pharmaceutical company [...]
Posted by: fuadelhibri on: November 13, 2010
The International Biomedical Research Alliance (IBRA) is a philanthropic organization that is dedicated to the support of the NIH-Oxford-Cambridge Scholars Program, which strives to establish the highest standards of excellence in training biomedical researchers, advance groundbreaking biomedical research, enrich the pool of leaders in the field, and eliminate barriers which frustrate the transfer of a [...]
Posted by: fuadelhibri on: November 4, 2010
ROCKVILLE, Md., Oct 28, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the acquisition of Trubion Pharmaceuticals, Inc., following a majority vote to approve the merger by Trubion stockholders at a special meeting conducted at Trubion’s Seattle headquarters on October 28, 2010. The acquisition provides Emergent with multiple, advanced [...]
Posted by: fuadelhibri on: October 23, 2010
ROCKVILLE, Md., Oct 13, 2010 — Emergent BioSolutions Inc. (NYSE: EBS) announced today it will report financial results for third quarter 2010 on Thursday November 4, 2010, after market close. Company management will host a conference call at 5:00 pm Eastern on November 4, 2010 to discuss the financial results for the third quarter and [...]
